pubmed.ncbi.nlm.nih.gov

Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment - PubMed

Review

Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment

P Gaudreault et al. Drug Saf. 1991 Jul-Aug.

Abstract

Benzodiazepines are among the most frequently prescribed drugs worldwide. This popularity is based not only on their efficacy but also on their remarkable safety. Pure benzodiazepine overdoses usually induce a mild to moderate central nervous system depression; deep coma requiring assisted ventilation is rare, and should prompt a search for other toxic substances. The severity of the CNS depression is influenced by the dose, the age of the patient and his or her clinical status prior to the ingestion, and the coingestion of other CNS depressants. In severe overdoses, benzodiazepines can occasionally induce cardiovascular and pulmonary toxicity, but deaths resulting from pure benzodiazepine overdoses are rare. Quantitative determinations of benzodiazepines are not useful in the clinical management of intoxicated patients since there is no correlation between serum concentrations and pharmacological and toxicological effects. Benzodiazepine overdoses occurring during pregnancy rarely induce serious morbidity in mothers or fetuses, although large doses administered near delivery can induce respiratory depression in neonates. The teratogenic potential of benzodiazepines remains controversial, but is probably small if it exists at all. There is clear evidence that the prolonged use of even therapeutic doses of benzodiazepines will lead to dependence. The risk of developing significant withdrawal symptoms is related to dosage and duration of treatment. Prevention of gastrointestinal absorption should be initiated in all intentional benzodiazepine overdoses. Forced diuresis and dialysis techniques are not indicated since they will not significantly accelerate the elimination of these agents. Intravenous administration of flumazenil, a pure benzodiazepine antagonist, effectively reverses benzodiazepine-induced CNS depression.

PubMed Disclaimer

Cited by

A New Tool to Tackle the Opioid Epidemic: Description, Utility, and Results from the Maine Diversion Alert Program.
Piper BJ, Desrosiers CE, Fisher HC, McCall KL, Nichols SD. Piper BJ, et al. Pharmacotherapy. 2017 Jul;37(7):791-798. doi: 10.1002/phar.1952. Epub 2017 Jun 30. Pharmacotherapy. 2017. PMID: 28543168 Free PMC article.
Polysubstance use in the U.S. opioid crisis.
Compton WM, Valentino RJ, DuPont RL. Compton WM, et al. Mol Psychiatry. 2021 Jan;26(1):41-50. doi: 10.1038/s41380-020-00949-3. Epub 2020 Nov 13. Mol Psychiatry. 2021. PMID: 33188253 Free PMC article. Review.
Clinical and economic evaluation of benzodiazepines: a value analysis.
Lyons JS, Larson DB, Hromco J. Lyons JS, et al. Pharmacoeconomics. 1992 Nov;2(5):397-407. doi: 10.2165/00019053-199202050-00007. Pharmacoeconomics. 1992. PMID: 10147052
A guide to the safety of CNS-active agents during breastfeeding.
Chisholm CA, Kuller JA. Chisholm CA, et al. Drug Saf. 1997 Aug;17(2):127-42. doi: 10.2165/00002018-199717020-00005. Drug Saf. 1997. PMID: 9285203 Review.
Drugs in blood and urine samples from victims of suspected exposure to drink spiking: A prospective observational study from Oslo, Norway.
Dalaker VM, Furuhaugen H, Brekke M, Bjørnaas MA, Krpo M, Øiestad EL, Vallersnes OM. Dalaker VM, et al. PLoS One. 2024 Jul 10;19(7):e0306191. doi: 10.1371/journal.pone.0306191. eCollection 2024. PLoS One. 2024. PMID: 38985694 Free PMC article.

References

1. J Pharm Sci. 1981 Oct;70(10):1104-7 - PubMed
1. Pharmacopsychiatria. 1983 May;16(3):71-6 - PubMed
1. N Engl J Med. 1983 Nov 24;309(21):1282-5 - PubMed
1. Br J Clin Pharmacol. 1986 Oct;22(4):421-8 - PubMed
1. J Forensic Sci. 1975 Jul;20(3):544-7 - PubMed

Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment - PubMed